“Final results for the vaccine that was rushed into trials in Guinea and later Sierra Leone show that it was highly effective against one of the most lethal known pathogens in existence. Ten days after vaccination, none of the trial subjects developed Ebola virus disease. The very few who did, in the days immediately following vaccination, are thought to have been infected already,” writes The Guardian.
The words ” thought to have been infected already” means that there is no proof that they were infected already. They might have been infected by the vaccine.
“Merck, Sharp & Dohme, the company manufacturing the vaccine, has received permission to go through fast-track procedures for a licence from the US and European regulatory authorities. It has committed to making 300,000 doses that will be ready for any emergency even before formal approval, with $5m (£4m) in funding from Gavi, the Vaccine Alliance.”
The scientists actually state they censored cases of people getting Ebola after vaccination from the results of this “novel” trial design, which had no control group.
“A priori, we defined that only cases of Ebola virus disease with an onset 10 or more days from randomisation were valid outcomes for the trial.19, 20 This was done to account for the incubation period of Ebola virus disease,26, 27 the time between onset of symptoms and laboratory confirmation and the unknown period between vaccination and a vaccine-induced protective immune response (lag period).19 Additionally, vaccinated cases of Ebola virus disease with an onset of more than 31 days after random assignment were censored to account for vaccination in the delayed clusters on day 21.19, ” says the study published in the Lancet.
A co author is WHO scientist Marie Paule Kieny.